Distribution of 14C-lomustine (14C-CCNU)-derived radioactivity following intravenous administration of three potential clinical formulations to rabbits.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001646:Bile / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D002250:Carbon Radioisotopes; D003510:Cyclohexanes / Q000031:analogs & derivatives; D004655:Emulsions; D000431:Ethanol; D005223:Fats; D007275:Injections, Intravenous; D008297:Male; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000378:metabolism*; D009821:Oils; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D011485:Protein Binding; D011817:Rabbits; D013997:Time Factors
D001798:Blood Proteins; D002250:Carbon Radioisotopes; D003510:Cyclohexanes; D004655:Emulsions; D005223:Fats; D009607:Nitrosourea Compounds; D009821:Oils; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D000431:Ethanol